Franklin Street Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.7M | Buy |
181,638
+2,421
| +1% | +$521K | 2.55% | 9 |
|
|
2026
Q1 | $39M | Sell |
179,217
-3,704
| -2% | -$822K | 2.39% | 11 |
|
|
2025
Q4 | $41.8M | Buy |
182,921
+4,257
| +2% | +$970K | 2.39% | 12 |
|
|
2025
Q3 | $41.4M | Buy |
178,664
+5,580
| +3% | +$1.14M | 2.38% | 13 |
|
|
2025
Q2 | $32.1M | Buy |
173,084
+17,405
| +11% | +$3.23M | 1.99% | 15 |
|
|
2025
Q1 | $32.6M | Sell |
155,679
-1,896
| -1% | -$369K | 2.3% | 9 |
|
|
2024
Q4 | $28M | Sell |
157,575
-16,081
| -9% | -$2.96M | 1.86% | 13 |
|
|
2024
Q3 | $34.3M | Sell |
173,656
-6,056
| -3% | -$1.13M | 2.31% | 9 |
|
|
2024
Q2 | $30.8M | Sell |
179,712
-9,083
| -5% | -$1.5M | 2.2% | 8 |
|
|
2024
Q1 | $34.4M | Sell |
188,795
-2,969
| -2% | -$512K | 2.54% | 11 |
|
|
2023
Q4 | $29.7M | Sell |
191,764
-12,268
| -6% | -$1.79M | 2.43% | 11 |
|
|
2023
Q3 | $30.4M | Buy |
204,032
+11,478
| +6% | +$1.68M | 2.7% | 8 |
|
|
2023
Q2 | $25.9M | Sell |
192,554
-1,889
| -1% | -$277K | 2.2% | 16 |
|
|
2023
Q1 | $31M | Sell |
194,443
-35,520
| -15% | -$5.43M | 2.82% | 8 |
|
|
2022
Q4 | $37.2M | Buy |
229,963
+12,880
| +6% | +$1.97M | 3.53% | 4 |
|
|
2022
Q3 | $29.1M | Sell |
217,083
-37,342
| -15% | -$5.36M | 2.95% | 7 |
|
|
2022
Q2 | $39M | Sell |
254,425
-21,213
| -8% | -$3.24M | 3.68% | 4 |
|
|
2022
Q1 | $44.7M | Sell |
275,638
-58,353
| -17% | -$8.48M | 3.61% | 4 |
|
|
2021
Q4 | $45.2M | Buy |
333,991
+48,826
| +17% | +$5.77M | 3.42% | 5 |
|
|
2021
Q3 | $30.8M | Buy |
285,165
+617
| +0.2% | +$70.5K | 2.61% | 10 |
|
|
2021
Q2 | $32.1M | Sell |
284,548
-10,134
| -3% | -$1.14M | 2.71% | 10 |
|
|
2021
Q1 | $31.9M | Buy |
294,682
+5,365
| +2% | +$574K | 2.96% | 9 |
|
|
2020
Q4 | $31M | Buy |
289,317
+4,087
| +1% | +$393K | 3.01% | 7 |
|
|
2020
Q3 | $25M | Buy |
285,230
+6,224
| +2% | +$586K | 2.69% | 9 |
|
|
2020
Q2 | $27.4M | Sell |
279,006
-7,160
| -3% | -$630K | 3.25% | 5 |
|
|
2020
Q1 | $21.8M | Buy |
286,166
+106,456
| +59% | +$9.07M | 3.18% | 5 |
|
|
2019
Q4 | $15.9M | Buy |
179,710
+59,830
| +50% | +$4.97M | 1.88% | 12 |
|
|
2019
Q3 | $9.08M | Sell |
119,880
-14,113
| -11% | -$968K | 1.15% | 38 |
|
|
2019
Q2 | $9.74M | Sell |
133,993
-36,696
| -21% | -$2.88M | 1.25% | 33 |
|
|
2019
Q1 | $13.8M | Sell |
170,689
-4,589
| -3% | -$375K | 1.92% | 13 |
|
|
2018
Q4 | $16.2M | Buy |
175,278
+595
| +0.3% | +$52.3K | 2.56% | 8 |
|
|
2018
Q3 | $16.5M | Sell |
174,683
-5,459
| -3% | -$518K | 2.24% | 11 |
|
|
2018
Q2 | $16.7M | Buy |
180,142
+578
| +0.3% | +$56.4K | 2.43% | 10 |
|
|
2018
Q1 | $17M | Buy |
179,564
+1,589
| +0.9% | +$175K | 2.55% | 9 |
|
|
2017
Q4 | $17.2M | Sell |
177,975
-6,310
| -3% | -$595K | 2.57% | 8 |
|
|
2017
Q3 | $16.4M | Sell |
184,285
-30,902
| -14% | -$2.35M | 2.69% | 5 |
|
|
2017
Q2 | $15.6M | Buy |
215,187
+23,908
| +12% | +$1.61M | 2.67% | 5 |
|
|
2017
Q1 | $12.5M | Buy |
191,279
+18,301
| +11% | +$1.15M | 2.2% | 7 |
|
|
2016
Q4 | $10.8M | Buy |
172,978
+8,800
| +5% | +$537K | 1.91% | 11 |
|
|
2016
Q3 | $10.4M | Buy |
164,178
+2,666
| +2% | +$173K | 1.88% | 9 |
|
|
2016
Q2 | $10M | Buy |
161,512
+16,501
| +11% | +$1.01M | 1.9% | 9 |
|
|
2016
Q1 | $8.28M | Buy |
145,011
+12,966
| +10% | +$723K | 1.64% | 14 |
|
|
2015
Q4 | $7.82M | Buy |
132,045
+5,381
| +4% | +$310K | 1.54% | 13 |
|
|
2015
Q3 | $6.89M | Buy |
126,664
+5,807
| +5% | +$378K | 1.37% | 16 |
|
|
2015
Q2 | $8.12M | Sell |
120,857
-188
| -0.2% | -$12.3K | 1.45% | 13 |
|
|
2015
Q1 | $7.09M | Sell |
121,045
-6,610
| -5% | -$399K | 1.3% | 17 |
|
|
2014
Q4 | $8.35M | Sell |
127,655
-6,785
| -5% | -$428K | 1.59% | 13 |
|
|
2014
Q3 | $7.76M | Sell |
134,440
-2,285
| -2% | -$127K | 1.48% | 14 |
|
|
2014
Q2 | $7.72M | Buy |
136,725
+8,270
| +6% | +$434K | 1.47% | 16 |
|
|
2014
Q1 | $6.6M | Sell |
128,455
-95
| -0.1% | -$4.8K | 1.32% | 20 |
|
|
2013
Q4 | $6.79M | Buy |
128,550
+7,363
| +6% | +$362K | 1.37% | 17 |
|
|
2013
Q3 | $5.42M | Buy |
121,187
+112,205
| +1,249% | +$4.97M | 1.22% | 27 |
|
|
2013
Q2 | $372K | Buy |
+8,982
| New | +$393K | 0.09% | 187 |
|
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Franklin Street Advisors's ABBV Position: Q2 2026 in Review
Franklin Street Advisors increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $521K and bringing the position to 181,638 shares worth $45.7M. The position accounts for 2.55% of the portfolio, ranked #9.
Franklin Street Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Franklin Street Advisors held 181,638 shares of AbbVie worth $45.7M as of Q2 2026.
- Franklin Street Advisors bought 2,421 AbbVie shares in Q2 2026, an estimated $521K.
- AbbVie made up 2.55% of Franklin Street Advisors's portfolio in Q2 2026, its #9 holding.
- Franklin Street Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.